University at Buffalo and New York Genome Center Collaboration Announced

As announced during Gov. Andrew M. Cuomo’s 2014 State of the State address, the University at Buffalo (UB) will partner with the New York Genome Center (NYGC) to accelerate recent advances in genomic medicine directly into clinical care. The governor’s investment in UB and NYGC is expected to spur the development of companies that will focus on diagnostics and information technology essential to breakthroughs in personalized medicine.

UB’s blend of expertise in medical research, life sciences innovation, and high-performance computing is key to this effort, and will provide NYCG with the expertise and supercomputing power to advance genomic medicine.

UB was selected as co-lead for this effort because of its expertise in high performance computing, genomics, medical research, and analysis of patient data. These strengths showcase the vast capabilities within UB’s Center for Computational Research (CCR), New York State Center of Excellence in Bioinformatics and Life Sciences, and the Institute for Healthcare Informatics (IHI). Each of these UB research centers reside on the Buffalo Niagara Medical Campus (BNMC).

Five companies will begin gaining access to the research and supercomputing resources, and contributing to the creation of new approaches to personalized medicine, diagnostics and technologies:

  • Computer Task Group (CTG) – a Buffalo-based information technology solutions firm with global business that develops innovative health care products and services.
  • Empire Genomics – created in 2006 by UB faculty member Norma Jean Nowak, PhD, a recognized leader in the field of genomics, from research started at Roswell Park Cancer Institute.
  • AESKU.Diagnostics – a Germany-based life sciences firm seeking to establish a new operation in medical diagnostics in Western New York.
  • Lineagen – a Salt Lake City, Utah-based firm seeking to expand its medical diagnostics business via co-location in Western New York
  • Personalized Medicine Pathways – a medical diagnostics company formed by CTG and Roswell Park Cancer Institute.

Read more at: UB Reporter: UB/NYGC Collaboration